人福醫藥(600079.SH):選舉李傑為公司董事長
格隆匯4月2日丨人福醫藥(600079.SH)公佈,公司於近日收到公司董事長王學海的書面辭職報告,王學海由於工作分工調整提出辭去公司董事長職務。
公司董事會對王學海在任職董事長期間為公司發展所做出的貢獻表示衷心感謝。該事項不會對公司治理、日常管理、生產經營及償債能力造成影響,王學海目前繼續擔任公司董事職務,其在公司下屬子公司的任職保持不變。
根據《公司法》及《公司章程》的有關規定,公司於2020年4月2日召開第九屆董事會第四十三次會議審議通過了《關於選舉公司第九屆董事會董事長的議案》,選舉李傑為公司董事長,任期自董事會審議通過之日起至公司第九屆董事會任期屆滿時止。
根據《公司章程》的相關規定,董事長為公司的法定代表人,因此公司法定代表人變更為李傑。公司將按照有關規定儘快完成法定代表人的工商變更登記手續。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.